The FDA announced on June 21 it has approved the Eversense Continuous Glucose Monitoring (CGM) system, the first fully implantable product of its kind. The device can be worn for up to 90 days, whereas most CGMs are replaced every week or two.

On Monday, June 18, the U.S. Food and Drug Administration (FDA) officially banned the use of trans fats, or partially hydrogenated oils (PHOs), in all foods sold in American restaurants and grocery stores.

Work stress is six times more likely to kill men than women who exhibit cardiometabolic disease despite otherwise being healthy, according to a new study published June 5 in The Lancet: Diabetes & Endocrinology.

A single blood sample to test both fasting glucose and hemoglobin A1c (HbA1c) may be sufficient to identify people with undiagnosed type 2 diabetes, according to a study published June 19 in the Annals of Internal Medicine.

Excessive weight gain during pregnancy increases the risk of preeclampsia in women who are pregnant for the first time, according to a new study published June 18 in Hypertension.

Type 2 diabetes (T2D) has been proven to raise the risk of cardiovascular complications, but a diagnosis doesn’t necessarily mean an inevitable slide toward those outcomes, according to the authors of a new study in the Journal of the American College of Cardiology.

Diabetes triples the risk of death from ischemic heart disease or stroke in women and doubles the risk in men with no previous vascular disease, according to new research published in The Lancet Diabetes & Endocrinology.

A new report from the Centers for Disease Control and Prevention (CDC) suggests 5.5 percent more rural Americans are obese than their metropolitan counterparts.